Editorial
Accepted on 30 Jun 2025
Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development
in Pharmacology of Anti-Cancer Drugs
- 188 views
Editorial
Accepted on 30 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 30 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 30 Jun 2025
in Cancer Epidemiology and Prevention
Original Research
Accepted on 30 Jun 2025
in Gastrointestinal Cancers: Colorectal Cancer
Original Research
Accepted on 30 Jun 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Case Report
Accepted on 30 Jun 2025
in Surgical Oncology
Original Research
Accepted on 30 Jun 2025
in Cancer Genetics
Case Report
Accepted on 30 Jun 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Review
Accepted on 30 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Case Report
Accepted on 30 Jun 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Review
Accepted on 30 Jun 2025
in Cancer Epidemiology and Prevention
Case Report
Accepted on 30 Jun 2025
in Pediatric Oncology
Original Research
Accepted on 30 Jun 2025
in Breast Cancer
Correction
Accepted on 30 Jun 2025
in Cancer Epidemiology and Prevention
Original Research
Accepted on 30 Jun 2025
in Cancer Imaging and Image-directed Interventions
Case Report
Accepted on 30 Jun 2025
in Thoracic Oncology